Gland Pharma Ltd
Gland Pharma's GHG Emissions Data Preview
In 2025, Gland Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Gland Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Verified Sources Behind Gland Pharma’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Gland Pharma’s data sources below and access millions more through our Disclosure Search.
Insights into Gland Pharma's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Gland Pharma amounted to 94,744 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Gland Pharma decreased by 2.21%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Gland Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Gland Pharma's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Gland Pharma were 13,920 metric tons of CO₂ equivalent (tCO₂e). a
Has Gland Pharma reduced its Scope 1 emissions over time?
Since 2023, Gland Pharma's Scope 1 emissions have increased by 16.68%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2024), Gland Pharma's Scope 1 emissions decreased by 11.54%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Gland Pharma's Scope 2 emissions?
In 2025, Gland Pharma reported Scope 2 greenhouse gas (GHG) emissions of 80,824 tCO₂e without specifying the calculation method. a
Has Gland Pharma reduced its Scope 2 emissions over time?
Since 2023, Gland Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Gland Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2024), Gland Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Gland Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Gland Pharma use for Scope 2 reporting?
In 2025, Gland Pharma reported its Scope 2 emissions using an unspecified methodology. a
Gland Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Gland Pharma’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Gland Pharma reported Scope 1 greenhouse gas (GHG) emissions of 13,920 tCO₂e and total revenues of USD 654 millions. This translates into an emissions intensity of 21.3 tCO₂e per millions USD. a
Gland Pharma's Scope 1 Emissions Intensity Compared to Peers
How does Gland Pharma's GHG emissions intensity compare to its peers?
In 2025, Gland Pharma reported a Scope 1 emissions intensity of 21.3 tCO₂e per millions USD. Compared to the peer group median of 28.64 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Gland Pharma rank on GHG emissions intensity within its industry?
In 2025, Gland Pharma ranked 9 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Gland Pharma is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a